Clinical Trial Detail

NCT ID NCT00828009
Title BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Eastern Cooperative Oncology Group
Indications

lung non-small cell carcinoma

Therapies

Cyclophosphamide

Bevacizumab

Paclitaxel

Emepepimut-S

Carboplatin

Age Groups: adult

No variant requirements are available.